Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.47 USD | +0.22% | +2.05% | +39.25% |
Mar. 18 | Allogene Therapeutics, Inc.(NasdaqGS:ALLO) added to S&P Biotechnology Select Industry Index | CI |
Mar. 15 | Allogene Therapeutics Files $500 Million Mixed Shelf | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.25% | 756M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock Allogene Therapeutics, Inc. - Nasdaq
- News Allogene Therapeutics, Inc.
- B. Riley Securities Lowers Allogene Therapeutics' PT to $18 from $21 After Servier's Termination of Participation in Development of CD19 Targeting Products, Maintains Buy Rating